Avalyn Pharma Inc. (AVLN) vs Ocular Therapeutix, Inc. (OCUL)
- Avalyn Pharma Inc. AVLN 27.88 −6.32%
- Ocular Therapeutix, Inc. OCUL 6.01 0.00%
Avalyn Pharma Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Avalyn Pharma Inc. and Ocular Therapeutix, Inc. are of similar size ($1.3B and $1.2B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −648.6%) and the lower return on invested capital (−127.6% vs 0.00%). Across the 11 metrics below, Avalyn Pharma Inc. leads on 8 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | AVLN | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 87.32% | 70.18% |
| Operating margin | 0.00% | (680.91%) | 0.00% |
| Net margin | 0.00% | (648.64%) | 0.00% |
| Free cash flow margin | 0.00% | (530.00%) | 0.00% |
| Return on equity | 0.00% | (93.48%) | (50.72%) |
| Return on assets | 0.00% | (64.30%) | (45.56%) |
| Return on invested capital | (127.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack